期刊文献+

缺血性脑血管病患者血清基质金属蛋白酶水平及影响因素分析 被引量:4

Evaluation and correlation analysis of matrix metalloproteinase-9 in ischemic cerebral vascular disease
原文传递
导出
摘要 目的 比较急性脑梗死、短暂脑缺血发作(TIA)和陈旧脑梗死患者血清基质金属蛋白酶-9(MMP-9)水平并分析其影响因素。方法 缺血性脑血管病患者136例,分为急性脑梗死组57例,TIA组22例,陈旧脑梗死组57例,进行神经功能评分及血压、血常规、血脂、血糖检查。依据ELISA法进行血MMP-9测定。结果 MMP-9水平分别为急性脑梗死患者(444.13±418.46)ng/ml,TIA患者(374.36±278.31)ng/ml,陈旧脑梗死患者(231.11±367.43)ng/ml。急性脑梗死和TIA患者血MMP-9水平明显高于陈旧脑梗死患者(P〈0.05)。MMP-9水平与血白细胞水平(r=0.192,P=0.025)、低密度脂蛋白(r=0.261,P=0.002)、收缩压(r=0.232,P=0.006)呈正相关;与高密度脂蛋白(r=-0.219,P=0.01)和血糖(r=-0.254,P=0.003)呈负相关。MMP-9与收缩压(β=0.259,P=0.001)、血白细胞(β=0.209,P=0.008)、低密度脂蛋白(β=0.586,P=0.000)、胆固醇(β=-0.458,P=0.007)和血糖(β=-0.200,P=0.014)具有线性关系。结论 MMP-9水平在急性脑梗死及TIA时升高,收缩压、血白细胞和低密度脂蛋白均可能为其影响因素。 Objective To evaluate serum matrix metalloproteinase-9 (MMP-9) in acute ischemic stroke, transient ischemic attack (TIA)and old ischemic stroke patients. Methods 57 acute ischemic stroke patients, 57 old ischemic stroke patients and 22 TIA patients were included. Medical history was recorded and routine examinations were conducted. Serum MMP-9 was evaluated using ELISA method. Results MMP-9 concentration was significandy elevated in acute ischemic stroke(444. 13±418.46)ng/ml and TIA patients (374. 36±278.31 )ng/ml, comparing with old ischemic stroke patients (231. 11±367.43 ) ng/ml (P 〈 0. 05 ). White blood cell count( r = 0. 192, P = 0. 025 ) , low density lipoprotein ( r = 0. 261 ,P = 0. 002 ) and systolic blood pressure ( r = 0. 232, P = 0. 006 ) positively correlated with MMP-9 level. High density lipoprotein ( r = - 0. 219, P = 0. 011 ) and blood glucose ( r = - 0. 254, P = 0. 003 ) negatively correlated with MMP-9 level. There was linear relationship between MMP-9 level and systolic blood pressure (β = 0. 259, P = 0. 001 ) , white blood cell count (β = 0. 209, P = 0. 008 ) , low density lipoprotein (β = 0. 586, P = 0. 000 ) , cholesterol(β = - 0.458, P = 0.007 ) and blood glucose (β = - 0.2, P =0. 014). Conclusion MMP-9 level elevated in acute ischemic stroke and TIA patients. SBP, WBC and LDL could be its influencing factors.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2007年第7期441-443,共3页 Chinese Journal of Neurology
基金 首都医学发展科研基金资助项目(2003-1002)
关键词 脑梗塞 脑缺血发作 短暂性 明胶酶B Brain infarction Ischemic attack, transient Gelatinase B
  • 相关文献

参考文献12

  • 1Planas AM, Sole S, Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis, 2001,8:834-846.
  • 2George SJ. Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin Investig Drugs, 2000,9 : 993-1007.
  • 3王新,黄如训,曾进胜.脑梗死急性期血清MMP-9的动态变化及其与脑梗死分型关系的研究[J].中国神经精神疾病杂志,2005,31(1):20-23. 被引量:48
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 5Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res, 1999,842:92-100.
  • 6Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke, 2001,32 : 1759-1766.
  • 7Verhoeven B, Hellings WE, Moll FL, et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vase Surg,2005, 42 : 1075-1081.
  • 8Justicia C, Panes J, Sole S, et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/ reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab, 2003,23 : 1430-1440.
  • 9Nakamura T, Matsuda T, Suzuki Y, et al. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans. Asaio J, 2003,49:430--434.
  • 10Fagan SC, Hess DC, Machado LS, et al. Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy, 2005, 25:387-395.

二级参考文献8

  • 1del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab, 2003, 23 (8) : 879.
  • 2Gasche Y, Fujimura M, Morita Fujimuro Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice:a possible rote in blood-brain barrier dysfunction. J Cereb Blood Flow Metab, 1999, 19(9): 1020.
  • 3Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinttse expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke, 2001, 32(8) : 1759.
  • 4Hamann GF. Unriddling the role of matrix metalloproteinases in human cerebral stroke. Stroke, 2003, 34(1): 40.
  • 5Lima JE, Takayanagui OM, Garcia LV, et al. Use of neuron-specific enolase for assessing the severity and outcome of neurological disorders inpatients. Braz J Med Biol Res, 2004, 37(1):19.
  • 6Hermmnn M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci, 2003, 21(3-4): 177.
  • 7Montaner J, Alvarez-Sabin J, Molina CA, et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke, 2001, 32(12): 2762.
  • 8Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke, 1998, 29(10): 2189.

共引文献33054

同被引文献49

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部